Suppressor lymphocytes in young and aged humans

Area of Science:

• Immunology
• Cellular Biology

Background:

• Concanavalin A (Con A) is a plant lectin commonly used to activate lymphocytes.
• Lymphocyte activation plays a crucial role in immune responses, including responses to mitogens and allogeneic cells.

Purpose of the Study:

• To investigate the suppressive effects of Con A-activated human lymphocytes on normal lymphocyte responses.
• To explore the characteristics of this suppressive phenomenon, including its dependence on activation time, dose, and individual variation.
• To examine age-related differences in Con A-induced lymphocyte suppressor activity and its potential link to autoantibody production.

Main Methods:

• Human peripheral lymphocytes were activated with varying concentrations and durations of Con A.
• The impact of Con A-activated lymphocytes on the response of other lymphocytes to mitogens and allogeneic cells was assessed.
• Mixed lymphocyte reactions were performed to evaluate suppression in both autologous and allogeneic settings.
• Lymphocyte suppressor activity was compared between young and aging human populations.

Main Results:

• Con A-activated lymphocytes exhibited dose-dependent suppression of normal lymphocyte responses to mitogens and allogeneic cells after a 24-hour activation period.
• Mitogenic Con A stimulation led to suppression, while submitogenic doses generally caused enhancement of lymphocyte responses.
• Significant individual variation was observed in the ability of lymphocytes to be suppressed.
• Lymphocytes from aging individuals showed a variable loss of Con A-induced suppressor activity compared to those from younger individuals.

Conclusions:

• Con A-activated lymphocytes possess potent immunomodulatory capabilities, capable of suppressing normal lymphocyte proliferation and reactivity.
• The observed age-related decline in suppressor activity suggests a potential mechanism contributing to the increased incidence of autoimmune phenomena in the elderly.
• Understanding these age-dependent immune alterations could inform strategies for managing age-related immune dysregulation and autoimmunity.